Placebo-controlled phase 1 trail, resveratrol (2.5 g p.o. twice per day) on Notch-1 signaling in low-grade gastrointestinal neuroendocrine tumors. The gene discussed is NOTCH1; the disease is digestive system neuroendocrine tumor, grade 1/2.